{"id":"W3109739095","doi":"10.1136/annrheumdis-2020-218870","title":"Upadacitinib for psoriatic arthritis refractory to biologics: SELECT-PsA 2","year":2020,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":233,"is_retracted":false,"has_abstract":true,"ca_institutions":"Probity Medical Research","funders":"AbbVie; Genentech; Celgene; Gilead Sciences; Amgen; Pfizer; Eli Lilly and Company","keywords":"Medicine; Placebo; Psoriatic arthritis; Internal medicine; Adverse effect; Rheumatology; Clinical endpoint; Arthritis; Pharmacology; Gastroenterology; Urology; Clinical trial; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001038161,0.0004384475,0.001124359,0.0002915334,0.0001992124,0.0004781876,0.0003282023,0.0004828173,0.00643106],"category_scores_gemma":[0.0005958634,0.0001618593,0.0008502403,0.0003171201,0.0003102027,0.0003039449,0.0002126222,0.0009815496,0.0006573992],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003920158,"about_ca_system_score_gemma":0.0006322158,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004277788,"about_ca_topic_score_gemma":0.001860541,"domain_scores_codex":[0.9997439,0.0001087008,0.00002957295,0.0000338879,0.00004091679,0.00004311082],"domain_scores_gemma":[0.9994872,0.0001378245,0.0001536809,0.00002661655,0.00003911569,0.0001556034],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.4580011,0.01115651,0.01302256,0.005199616,0.001888995,0.0007839712,0.0002023487,0.002209137,0.03122436,0.0007115587,0.009690202,0.4659097],"study_design_scores_gemma":[0.6766242,0.2408162,0.03642682,0.0006517287,0.003151627,0.00392036,0.000112031,0.002794734,0.01246472,0.0006354086,0.02231915,0.00008309801],"study_design_candidate":"randomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9548689,0.03694986,0.0008080247,0.000936223,0.0002055912,0.001102634,0.0008379322,0.0001050462,0.004185851],"genre_scores_gemma":[0.9832861,0.0108318,0.001313442,0.0007274006,0.0003157725,0.0006845236,0.001018779,0.00001235637,0.001809684],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00643106,"threshold_uncertainty_score":0.02151406,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.07046193175246603,"score_gpt":0.3277423721760776,"score_spread":0.2572804404236116,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}